Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Fluorescent Proteins Enhance UVC PDT of Cancer Cells

MASASHI MOMIYAMA, ATSUSHI SUETSUGU, HIROAKI KIMURA, HIROYUKI KISHIMOTO, RYOICHI AKI, AKIMITSU YAMADA, HARUMI SAKURADA, TAKASHI CHISHIMA, MICHAEL BOUVET, NATALIA N. BULGAKOVA, ITARU ENDO and ROBERT M. HOFFMAN
Anticancer Research October 2012, 32 (10) 4327-4330;
MASASHI MOMIYAMA
1AntiCancer, Inc., San Diego, CA, U.S.A.
2Department of Surgery, University of California, San Diego, CA, U.S.A.
3Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATSUSHI SUETSUGU
1AntiCancer, Inc., San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI KIMURA
1AntiCancer, Inc., San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI KISHIMOTO
1AntiCancer, Inc., San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYOICHI AKI
1AntiCancer, Inc., San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIMITSU YAMADA
3Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUMI SAKURADA
3Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI CHISHIMA
3Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL BOUVET
2Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NATALIA N. BULGAKOVA
4General Physics Institute, Russian Academy of Sciences, Moscow, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ITARU ENDO
3Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT M. HOFFMAN
1AntiCancer, Inc., San Diego, CA, U.S.A.
2Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: all@anticancer.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Cancer cells, with and without fluorescent protein expression, were irradiated with various doses of UVC (100, 400, and 600 J/m2). Dual-color Lewis lung carcinoma cells (LLC) and U87 human glioma cells, expressing GFP in the nucleus and RFP in the cytoplasm and non-colored LLC and U87 cells were cultured in 96-well plates. Eight hours after seeding, the cells were irradiated with the various doses of UVC. The resulting cell number was determined after 24 hours. Compared to non-colored LLC cells, the number of dual-color LLC cells decreased significantly due to UVC irradiation with 100 J/m2 (p=0.003). Although there was no significant difference in the number of dual-color and non-colored U87 cells after 100 J/m2 UVC irradiation (p=0.852), the number of dual-color U87 cells decreased significantly with respect to non-colored cells due to UVC irradiation with 400 J/m2 and 600 J/m2 (p=0.011 and p=0.009, respectively). Thus, both dual-color LLC and dual-color U87 cells were more sensitive to UVC light than non-colored LLC and U87 cells. These results suggest that the expression of fluorescent proteins in cancer cells can enhance photodynamic therapy (PDT) using UVC and possibly with other wavelengths of light as well.

  • Lewis lung carcinoma
  • U87 glioma
  • GFP
  • RFP
  • UV light
  • cell killing

Photodynamic therapy (PDT) has been shown to be effective for certain cancer types (1). UV light has been used for the phototherapy of cutaneous malignancies. Psoralen plus UVA (PUVA) and narrowband UVB were found to be effective (2-4). However, the effect of UV light on cancer cells is not well-understood (5-7). UV light has been mainly used for skin cancer, since short wavelength light does not penetrate deeply through the skin (8).

Our laboratory pioneered in vivo imaging with fluorescent proteins (9-11). We have also developed dual-color cancer cells, in which red fluorescent protein (RFP) is expressed in the cytoplasm and green fluorescent protein (GFP), linked to histone H2B, is expressed in the nucleus. Nuclear GFP expression enables for visualization of nuclear dynamics such as apoptosis, whereas simultaneous cytoplasmic RFP expression enables visualization of nuclear-cytoplasmic ratios as well as cytoplasmic and nuclear shape changes (12-15).

We previously investigated the cell-killing efficacy of UV light on various cancer cell lines expressing GFP in the nucleus and RFP in the cytoplasm in vitro and in vivo (8).

The efficacy of fluorescence-guided ultraviolet C (UVC) irradiation on the growth of murine melanoma expressing GFP in the ear of RFP mice was previously determined and found to inhibit melanoma growth and also damaged blood vessels in the tumor (16).

The present study directly compares the cell-killing efficacy of UVC on cancer cells with and without fluorescent protein expression in order to determine if fluorescent proteins enhance PDT.

Materials and Methods

Cells. To establish Lewis lung carcinoma (LLC) or U87 human glioma (U87) cells expressing GFP in the nucleus and RFP in the cytoplasm, the cells were transfected with retroviral RFP and H2B-GFP vectors as previously described (12, 14, 17, 18). Dual-color LLC and U87 cells were maintained in DMEM medium (Hyclone Laboratories, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories). The cells were incubated at 37°C in a humidified atmosphere of 5% CO2 in air. The cells were collected after trypsinization and stained with trypan blue (Sigma-Aldrich, St. Louis, MO, USA). Only viable cells were counted with a hemocytometer (Hausser Scientific, Horsham, PA, USA).

Sensitivity of dual-color and non-colored cancer cells to UVC light in vitro. To determine if UV-induced cancer cell death is enhanced by the expression of fluorescent proteins, dual-color LLC cells and U87 glioma and non-colored LLC cells and dual-color U87 glioma cells and non-color U87 glioma cells (8000/well) were plated in 100 μl medium per well in 96-well plates. Eight hours after seeding, the cells were irradiated with various doses of UVC (0-600 J/m2) (8). Cell number was measured after 24 hr with the CellTiter96 Aqueous Non-radioactive Assay (Promega Corp., Madison, WI, USA). Five wells were used for each cell line and each UV dose.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A) Dual-color mouse LLC cells. B) Dual-color human U87 glioma cells. The dual-color cancer cells express GFP, linked to histone H2B, in the nucleus and RFP in the cytoplasm. Cells were cultured in vitro, as described in the Material and Methods. Cells were observed under confocal microscopy using the FV1000 (Olympus Corp., Tokyo, Japan).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Efficacy of UVC irradiation on fluorescent protein-expressing and non-colored cancer cell lines in vitro. UVC was irradiated at various doses (100, 400, and 600 J/m2). Dual-color LLC (LLC-D) cells and non-colored LLC (LLC-NC) cells (8,000/well) were plated in 100 μl cell culture medium per well in 96-well plates. Eight hours after seeding, the cells were irradiated with various doses of UVC (0-600 J/m2). The cell number was determined after 24 hours. Compared to non-colored LLC cells, the number of dual-color LLC cells decreased significantly due to UVC irradiation with 100 J/m2 (p=0.003). Although there was no significant difference in the number of dual-color and non-colored U87 cells after 100 J/m2 UVC irradiation (p=0.852), the number of dual-color U87 cells (U87-D) decreased significantly with respect to non-colored U87 cells (U87-NC) due to UVC irradiation with 400 J/m2 and 600 J/m2 (p=0.011 and p=0.009, respectively). Both dual-color LLC and dual-color U87 cells were more sensitive to UVC light than non-colored LLC and U87 cells. Five wells were used for each cell line and each UV dose. The experimental data are expressed as the mean ± SD. Statistical analysis was performed using the Student's t-test.

Statistical analysis. The experimental data are expressed as the mean ± SD. Statistical analysis was performed using the Student's t-test or the Kruskal-Wallis test. A p-value of less than 0.05 indicated a significant difference.

Results

Images of LLC and U87 cells expressing GFP in the nucleus and RFP in the cytoplasm are shown Figure 1A and B.

In vitro experiments indicated increased efficacy of UVC light on cancer cells labeled with fluorescent proteins (Figure 2). Compared to non-colored LLC cells, the number of dual-color LLC cells decreased significantly due to UVC irradiation with 100 J/m2 (p=0.003).

Although there was no significant difference in the number of dual-color and non-colored U87 cells after 100 J/m2 UVC irradiation (p=0.852), the number of dual-color U87 cells decreased significantly due to UVC irradiation with 400 J/m2 and 600 J/m2 (p=0.011 and p=0.009, compared to non-colored cells, respectively).

Discussion

Fluorescent-protein-expressing dual-color cancer cells were more sensitive to UVC light than non-colored cancer cells (Figure 2). Therefore, UVC light may be a powerful tool for treatment of cancer cells expressing fluorescent reporters which now can be introduced selectively to cancer cells in vivo (19, 20).

UVC light does not deeply penetrate tissue. UVC light, however, could be of potential use to sterilize the surgical bed after tumor resection. Fluorescent proteins are also excited at longer wavelengths. GFP is, for example, excited at 484 nm and RFP at 563 nm (21). Our results, thus, open up the possibility of PDT using fluorescent proteins at longer wavelengths to enhance PDT. Since longer wavelength light penetrates tissue more deeply, PDT of cancer cells with fluorescent protein expression could be used for more deep-seated cancers.

Acknowledgements

These studies were supported in part by National Cancer Institute grants CA132971 and 142669.

Footnotes

  • Conflicts of Interest

    None of the Authors has any conflicts of interest regarding this study.

  • Received July 13, 2012.
  • Accepted August 10, 2012.
  • Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Castano AP,
    2. Liu Q,
    3. Hamblin MR
    : A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br J Cancer 94: 391-397, 2006.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Gilchrest BA,
    2. Parrish JA,
    3. Tanenbaum L,
    4. Haynes HA,
    5. Fitzpatrick TB
    : Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 38: 683-689, 1976.
    OpenUrlCrossRefPubMed
    1. Hofer A,
    2. Cerroni L,
    3. Kerl H,
    4. Wolf P
    : Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 135: 1377-1380, 1999.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Carter J,
    2. Zug KA
    : Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J Am Acad Dermatol 60: 39-50, 2009.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Zacal N,
    2. Rainbow AJ
    : Photodynamic therapy resistant human colon carcinoma HT29 cells show cross-resistance to UVA but not UVC Light. Photochem Photobiol 83: 730-737, 2007.
    OpenUrlPubMed
    1. Benencia F,
    2. Courrèges MC,
    3. Coukos G
    : Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. J Transl Med 6: 21, 2008.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kim SC,
    2. Park S-S,
    3. Lee YJ
    : Effect of UV irradiation on colorectal cancer cells with acquired TRAIL resistance. J Cell Biochem 104: 1172-1180, 2008.
    OpenUrlPubMed
  6. ↵
    1. Kimura H,
    2. Lee C,
    3. Hayashi K,
    4. Yamauchi K,
    5. Yamamoto N,
    6. Tsuchiya H,
    7. Tomita K,
    8. Bouvet M,
    9. Hoffman RM
    : UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 110: 1439-1446, 2010.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Chishima T,
    2. Miyagi Y,
    3. Wang X,
    4. Yamaoka H,
    5. Shimada H,
    6. Moossa AR,
    7. Hoffman RM
    : Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 57: 2042-2047, 1997.
    OpenUrlAbstract/FREE Full Text
    1. Yang M,
    2. Baranov E,
    3. Jiang P,
    4. Sun F-X,
    5. Li X-M,
    6. Li L,
    7. Hasegawa S,
    8. Bouvet M,
    9. Al-Tuwaijri M,
    10. Chishima T,
    11. Shimada H,
    12. Moossa AR,
    13. Penman S,
    14. Hoffman RM
    : Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA 97: 1206-1211, 2000.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Hoffman RM
    : The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Reviews Cancer 5: 796-806, 2005.
    OpenUrlPubMed
  9. ↵
    1. Yamamoto N,
    2. Jiang P,
    3. Yang M,
    4. Xu M,
    5. Yamauchi K,
    6. Tsuchiya H,
    7. Tomita K,
    8. Wahl GM,
    9. Moossa AR,
    10. Hoffman RM
    : Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res 64: 4251-4256, 2004.
    OpenUrlAbstract/FREE Full Text
    1. Yamauchi K,
    2. Yang M,
    3. Jiang P,
    4. Yamamoto N,
    5. Xu M,
    6. Amoh Y,
    7. Tsuji K,
    8. Bouvet M,
    9. Tsuchiya H,
    10. Tomita K,
    11. Moossa AR,
    12. Hoffman RM
    : Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration. Cancer Res 65: 4246-4252, 2005.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Hoffman RM,
    2. Yang M
    : Subcellular imaging in the live mouse. Nature Protoc 1: 775-782, 2006.
    OpenUrlCrossRef
  11. ↵
    1. Jiang P,
    2. Yamauchi K,
    3. Yang M,
    4. Tsuji K,
    5. Xu M,
    6. Maitra A,
    7. Bouvet M,
    8. Hoffman RM
    : Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle 5: 1198-1201, 2006.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Tsai M-H,
    2. Aki R,
    3. Amoh Y,
    4. Hoffman RM,
    5. Katsuoka K,
    6. Kimura H,
    7. Lee C,
    8. Chang C-H
    : GFP-fluorescence-guided UVC irradiation inhibits melanoma growth and angiogenesis in nude mice. Anticancer Res 30: 3291-3294, 2010.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Hoffman RM,
    2. Yang M
    : Color-coded fluorescence imaging of tumor-host interactions. Nature Protoc 1: 928-935, 2006.
    OpenUrlCrossRef
  14. ↵
    1. Hoffman RM,
    2. Yang M
    : Whole-body imaging with fluorescent proteins. Nature Protoc 1: 1429-1438, 2006.
    OpenUrlCrossRef
  15. ↵
    1. Kishimoto H,
    2. Zhao M,
    3. Hayashi K,
    4. Urata Y,
    5. Tanaka N,
    6. Fujiwara T,
    7. Penman S,
    8. Hoffman RM
    : In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci USA 106: 14514-14517, 2009.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Kishimoto H,
    2. Urata Y,
    3. Tanaka N,
    4. Fujiwara T,
    5. Hoffman RM
    : Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol Cancer Ther 8: 3001-3008, 2009.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Hoffman R.M.
    1. Walker John M.
    1. Zimmer M
    : What does it take to improve existing fluorescent proteins for in vivo imaging applications? (Chap. 16). In: In Vivo Cellular Imaging Using Fluorescent Proteins: Methods and Protocols. Hoffman R.M., ed. Methods in Molecular Biology, Vol. 872. Walker John M., series ed. Humana Press (Springer Science+Business Media New York), 2012.
PreviousNext
Back to top

In this issue

Anticancer Research: 32 (10)
Anticancer Research
Vol. 32, Issue 10
October 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fluorescent Proteins Enhance UVC PDT of Cancer Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Fluorescent Proteins Enhance UVC PDT of Cancer Cells
MASASHI MOMIYAMA, ATSUSHI SUETSUGU, HIROAKI KIMURA, HIROYUKI KISHIMOTO, RYOICHI AKI, AKIMITSU YAMADA, HARUMI SAKURADA, TAKASHI CHISHIMA, MICHAEL BOUVET, NATALIA N. BULGAKOVA, ITARU ENDO, ROBERT M. HOFFMAN
Anticancer Research Oct 2012, 32 (10) 4327-4330;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Fluorescent Proteins Enhance UVC PDT of Cancer Cells
MASASHI MOMIYAMA, ATSUSHI SUETSUGU, HIROAKI KIMURA, HIROYUKI KISHIMOTO, RYOICHI AKI, AKIMITSU YAMADA, HARUMI SAKURADA, TAKASHI CHISHIMA, MICHAEL BOUVET, NATALIA N. BULGAKOVA, ITARU ENDO, ROBERT M. HOFFMAN
Anticancer Research Oct 2012, 32 (10) 4327-4330;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate
  • Efficacy of the Combination of a PARP Inhibitor and UVC on Cancer Cells as Imaged by Focus Formation by the DNA Repair-related Protein 53BP1 Linked to Green Fluorescent Protein
  • Use of {alpha}v Integrin Linked to Green Fluorescent Protein in Osteosarcoma Cells and Confocal Microscopy to Image Molecular Dynamics During Lung Metastasis in Nude Mice
  • The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy
  • Single Cell Time-lapse Imaging of Focus Formation by the DNA Damage-Response Protein 53BP1 after UVC Irradiation of Human Pancreatic Cancer Cells
  • Novel Topical Photodynamic Therapy of Prostate Carcinoma Using Hydroxy-aluminum Phthalocyanine Entrapped in Liposomes
  • Google Scholar

More in this TOC Section

  • Enhanced DNA Double-strand Break Induction by Carbon Ions Under Intratumoral Hypoxia
  • C-myc Oncogene Numerical Imbalances Analysis in Laryngeal Squamous Cell Carcinoma
  • Association of Interleukin-12A Genotypes With Nasopharyngeal Carcinoma Risk
Show more Experimental Studies

Similar Articles

Keywords

  • Lewis lung carcinoma
  • U87 glioma
  • GFP
  • RFP
  • UV light
  • cell killing
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire